Drug major Sun Pharmaceutical Industries Ltd on Monday announced the launch of ready-to-administer cancer drug Gemcitabine InfuSMART in Europe.
InfuSMART is a technology in which oncology/cancer products were developed in a ready-to-administer bag, the company said in a statement.
“Until now, compounding of oncology products was done at compounding centres or compounded in hospital pharmacies, an extra step before the medicine can be administered to patients,” the company said.
Sun Pharma claimed that it is the world’s first pharmaceutical company to manufacture and launch a licensed ready-to-administer oncology product.
Over the next few months, Sun Pharma will launch Gemcitabine InfuSMART across Netherlands, Britain, Spain, Germany, Italy and France.